Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR ; volume:16 ; number:1 ; day:22 ; month:4 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of ovarian research ; 16, Heft 1 (22.4.2023), 1-14, 12.2023
- Creator
-
Chien, Wenwen
Tyner, Jeffrey W.
Gery, Sigal
Zheng, Yueyuan
Li, Li-Yan
Gopinatha Pillai, Mohan Shankar
Nam, Chehyun
Bhowmick, Neil A.
Lin, De-Chen
Koeffler, H. Phillip
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-023-01160-y
- URN
-
urn:nbn:de:101:1-2023090209013832981337
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chien, Wenwen
- Tyner, Jeffrey W.
- Gery, Sigal
- Zheng, Yueyuan
- Li, Li-Yan
- Gopinatha Pillai, Mohan Shankar
- Nam, Chehyun
- Bhowmick, Neil A.
- Lin, De-Chen
- Koeffler, H. Phillip
- SpringerLink (Online service)
Other Objects (12)
Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
ATR
SOX17 expression in ovarian clear cell carcinoma
ATR-Material
ATR-Material
ATR-Material
a-tr
ATR ZAP
AtR
ATR-Material
Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
ATR
SOX17 expression in ovarian clear cell carcinoma
ATR-Material
ATR-Material
ATR-Material
a-tr
ATR ZAP
AtR
ATR-Material
Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
ATR
SOX17 expression in ovarian clear cell carcinoma
ATR-Material
ATR-Material
ATR-Material
a-tr
ATR ZAP
AtR